Literature DB >> 6325953

Beta-adrenoceptor changes in human lymphocytes, induced by dynamic exercise.

O E Brodde, A Daul, N O'Hara.   

Abstract

In 10 healthy volunteers the effects of acute increases in concentrations of catecholamines in plasma induced by dynamic exercise (on a bicycle for 15 min at 80% of maximum heart rate) on lymphocyte beta 2-adrenoceptor density (determined by (+/-)-125iodocyanopindolol binding) and -responsiveness (determined by cyclic AMP responses to 10 mumol/l isoprenaline) were investigated. Immediately after exercise plasma catecholamines were increased about 4-fold; concomitantly receptor density and cyclic AMP production increased 55% and 65%, respectively. One hour after exercise beta-adrenoceptor density and plasma catecholamines had reached values, which were not significantly different from pre-exercise values, while cyclic AMP production was significantly diminished. It is concluded, that acute increases in concentrations of catecholamines in plasma may increase beta-adrenoceptor density and - responsiveness in human lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325953     DOI: 10.1007/bf00506201

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 2.  Biochemical assessment of adrenoceptor function and regulation: new directions and clinical relevance.

Authors:  S R Nahorski; D B Barnett
Journal:  Clin Sci (Lond)       Date:  1982-08       Impact factor: 6.124

3.  The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol.

Authors:  O E Brodde; G Engel; D Hoyer; K D Bock; F Weber
Journal:  Life Sci       Date:  1981-11-23       Impact factor: 5.037

4.  Regulation of the beta-adrenergic receptor by methylation of membrane phospholipids.

Authors:  W J Strittmatter; F Hirata; J Axelrod
Journal:  Adv Cyclic Nucleotide Res       Date:  1981

Review 5.  Sympathetic nervous activity during exercise.

Authors:  N J Christensen; H Galbo
Journal:  Annu Rev Physiol       Date:  1983       Impact factor: 19.318

6.  Human lymphocytes as a model for beta-adrenergic receptors in clinical investigation.

Authors:  R Landmann; E Bürgisser; F R Bühler
Journal:  J Recept Res       Date:  1983

7.  Acute changes in noradrenaline levels do not alter lymphocyte beta-adrenergic receptor concentrations in man.

Authors:  J R Sowers; M Connelly-Fittinghoff; M L Tuck; J F Krall
Journal:  Cardiovasc Res       Date:  1983-03       Impact factor: 10.787

8.  A sensitive method for determination of conjugated catecholamines in blood plasma.

Authors:  M Nagel; H J Schümann
Journal:  J Clin Chem Clin Biochem       Date:  1980-07

9.  Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number.

Authors:  J F Tohmeh; P E Cryer
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

10.  Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines.

Authors:  R D Feldman; L E Limbird; J Nadeau; G A FitzGerald; D Robertson; A J Wood
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more
  17 in total

1.  Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects.

Authors:  Y Zoukos; T Thomaides; D V Pavitt; J P Leonard; M L Cuzner; C J Mathias
Journal:  Clin Auton Res       Date:  1992-06       Impact factor: 4.435

Review 2.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

Review 3.  The leucocytosis of exercise. A review and model.

Authors:  D A McCarthy; M M Dale
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

Review 4.  Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  Relation between beta-adrenergic receptor density and lymphocyte proliferation associates with acute stress.

Authors:  L Redwine; F Jenkins; A Baum
Journal:  Int J Behav Med       Date:  1996

6.  Training-overtraining: influence of a defined increase in training volume vs training intensity on performance, catecholamines and some metabolic parameters in experienced middle- and long-distance runners.

Authors:  M Lehmann; P Baumgartl; C Wiesenack; A Seidel; H Baumann; S Fischer; U Spöri; G Gendrisch; R Kaminski; J Keul
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

7.  Physical activity decreases the number of beta-adrenergic receptors on human lymphocytes.

Authors:  W Krawietz; E M Klein; C Unterberg; M Ackenheil
Journal:  Klin Wochenschr       Date:  1985-01-15

8.  Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues.

Authors:  P T Larsson; A Martinsson; G Olsson; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 9.  Blood hormones as markers of training stress and overtraining.

Authors:  A Urhausen; H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-10       Impact factor: 11.136

10.  Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal.

Authors:  S Braune; M Albus; M Fröhler; T Höhn; G Scheibe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.